Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$6.81 - $9.71 $308,996 - $440,581
-45,374 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$14.83 - $26.72 $191,307 - $344,688
12,900 Added 39.72%
45,374 $704,000
Q4 2019

Feb 11, 2020

BUY
$9.77 - $24.6 $317,270 - $798,860
32,474 New
32,474 $799,000
Q3 2019

Nov 07, 2019

SELL
$10.17 - $13.86 $217,576 - $296,520
-21,394 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$11.43 - $15.12 $16,002 - $21,168
1,400 Added 7.0%
21,394 $268,000
Q1 2019

May 08, 2019

BUY
$5.98 - $13.98 $119,564 - $279,516
19,994 New
19,994 $248,000
Q1 2018

May 11, 2018

SELL
$12.5 - $19.75 $182,500 - $288,350
-14,600 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$11.55 - $20.1 $168,630 - $293,460
14,600
14,600 $183,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.